News

Barchart on MSN5d
Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing
Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...
MarketBeat on MSN5d
JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now
After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price ...
Barchart on MSN5d
Kenvue's Q2 2025 Earnings: What to Expect
Skillman, New Jersey-based Kenvue Inc. (KVUE) operates as a global consumer health company. Valued at $41.9 billion by market ...
Investing.com UK4d
Kenvue outlook revised to negative by S&P amid strategic review
The consumer health company also disclosed its CEO’s departure, following its CFO replacement earlier this year, and appointed an interim chief executive. Preliminary second-quarter 2025 results show ...
Kenvue: New CEO, Watch The Dividend (Rating Downgrade)
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Assessing Kenvue: Insights From 6 Financial Analysts
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...
Cosmetics Business6d
Kenvue ousts CEO and launches strategic review amid struggling sales
Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...